Home/Filings/4/0001894562-25-000002
4//SEC Filing

Reine Allan 4

Accession 0001894562-25-000002

CIK 0001894562other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 8:11 PM ET

Size

5.4 KB

Accession

0001894562-25-000002

Insider Transaction Report

Form 4
Period: 2025-02-27
Reine Allan
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (right to buy)

    2025-02-27+275,000275,000 total
    Exercise: $2.42Exp: 2035-02-27Common Stock (275,000 underlying)
Footnotes (1)
  • [F1]1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of February 27, 2025, subject to the Reporting Person's continued service on each such vesting date.

Issuer

Prime Medicine, Inc.

CIK 0001894562

Entity typeother

Related Parties

1
  • filerCIK 0001714023

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:11 PM ET
Size
5.4 KB